Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for MHTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
September 30, 2022 0.00%
June 30, 2022 97.56%
March 31, 2022
December 31, 2021
September 30, 2021
June 30, 2021 0.00%
March 31, 2021
December 31, 2020
September 30, 2020
June 30, 2020 0.00%
March 31, 2020
December 31, 2019 0.00%
September 30, 2019 0.00%
June 30, 2019 98.00%
March 31, 2019
December 31, 2018
September 30, 2018
June 30, 2018
March 31, 2018
December 31, 2017
September 30, 2017 0.00%
June 30, 2017 -492.7%
March 31, 2017 0.00%
December 31, 2016 0.00%
September 30, 2016 0.00%
Date Value
June 30, 2016 0.00%
March 31, 2016
December 31, 2015 0.00%
September 30, 2015
June 30, 2015 0.00%
March 31, 2015 0.00%
December 31, 2014 0.00%
September 30, 2014 67.72%
June 30, 2014 66.67%
March 31, 2014 72.22%
December 31, 2013
September 30, 2013 -170.6%
June 30, 2013 76.44%
March 31, 2013 89.64%
December 31, 2012 74.01%
September 30, 2012 73.41%
June 30, 2012 74.42%
March 31, 2012 73.10%
December 31, 2011 57.80%
September 30, 2011 56.73%
June 30, 2011 83.72%
March 31, 2011 83.63%
December 31, 2010 98.46%
September 30, 2010 77.91%
June 30, 2010 78.36%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Tenax Therapeutics, Inc. --
Exicure, Inc. --
Century Therapeutics, Inc. --
Absci Corp. -747.8%
Celularity, Inc. -123.6%